| 6214- | CUR, | Curcumin Nanoparticles-related Non-invasive Tumor Therapy, and Cardiotoxicity Relieve |
| - | Review, | CardioV, | NA |
| 6215- | CUR, | Curcumin: biochemistry, pharmacology, advanced drug delivery systems, and its epigenetic role in combating cancer |
| - | Review, | Var, | NA |
| 6216- | CUR, | Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials |
| - | Review, | Var, | NA |
| 6232- | CUR, | Rad, | Chemo, | The Effectiveness of Curcumin in Treating Oral Mucositis Related to Radiation and Chemotherapy: A Systematic Review |
| - | Review, | Var, | NA |
| 6231- | CUR, | Curcumin induces apoptosis in human hepatocellular carcinoma cells by decreasing the expression of STAT3/VEGF/HIF-1α signaling |
| - | in-vitro, | Liver, | HepG2 |
| 6230- | CUR, | Dual redox effects of 2,6-bis-(4-hydroxyl-3-methoxybenzylidene) cyclohexanone (BHMC) on human liver cancer cells, HepG2 via ROS, glutathione and Nrf2/Keap1 pathway |
| - | in-vitro, | Liver, | HepG2 |
| 6229- | CUR, | Curcumin inhibits NF-kB and Wnt/β-catenin pathways in cervical cancer cells |
| - | in-vitro, | Cerv, | NA |
| 6228- | CUR, | A pharmacokinetic study and critical reappraisal of curcumin formulations enhancing bioavailability |
| - | Study, | Nor, | NA |
| 6212- | CUR, | Rad, | Radiosensitization and Radioprotection by Curcumin in Glioblastoma and Other Cancers |
| - | Review, | Var, | NA |
| 6226- | CUR, | Rad, | Analysis of Curcumin as a Radiosensitizer in Cancer Therapy with Serum Survivin Examination: Randomised Control Trial |
| - | Trial, | Cerv, | NA |
| 6225- | CUR, | Natural products for enhancing the sensitivity or decreasing the adverse effects of anticancer drugs through regulating the redox balance |
| - | Review, | Var, | NA |
| 6224- | CUR, | Thioredoxin reductase: An emerging pharmacologic target for radiosensitization of cancer |
| - | Review, | Var, | NA |
| 6223- | CUR, | Curcumin Rewires the Tumor Metabolic Landscape: Mechanisms and Clinical Prospects |
| - | Review, | Var, | NA |
| 6222- | CUR, | Anticancer Molecular Mechanisms of Curcuminoids: An Updated Review of Clinical Trials |
| - | Review, | Var, | NA |
| 6221- | CUR, | Oxidative Stress and Cancer: Harnessing the Therapeutic Potential of Curcumin and Analogues Against Cancer |
| - | Review, | Var, | NA |
| 6219- | CUR, | Natural Products and Altered Metabolism in Cancer: Therapeutic Targets and Mechanisms of Action |
| - | Review, | Var, | NA |
| 6218- | CUR, | Exploring the Thioredoxin System as a Therapeutic Target in Cancer: Mechanisms and Implications |
| - | Review, | Var, | NA |
| 6217- | CUR, | Curcumin: a therapeutic strategy in cancers by inhibiting the canonical WNT/β-catenin pathway |
| - | Review, | Var, | NA |
| 6209- | CUR, | Curcumin as a complementary treatment in oncological therapy: a systematic review |
| - | Review, | Var, | NA |
| 6208- | CUR, | Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial |
| - | Trial, | Nor, | NA |
| 6210- | CUR, | Potential Roles and Mechanisms of Curcumin and its Derivatives in the Regulation of Ferroptosis |
| - | in-vitro, | Var, | NA |
| 6720- | CUR, | SFN, | DHCA, | Synergistic Combinations of Curcumin, Sulforaphane, and Dihydrocaffeic Acid against Human Colon Cancer Cells |
| - | in-vitro, | Colon, | HT29 | - | in-vitro, | Colon, | Caco-2 | - | in-vitro, | Nor, | FHC |
| 6770- | CUR, | A Review on Antibacterial, Antiviral, and Antifungal Activity of Curcumin |
| - | Review, | Nor, | NA |
| 2307- | CUR, | Cell-Type Specific Metabolic Response of Cancer Cells to Curcumin |
| - | in-vitro, | Colon, | HT29 | - | in-vitro, | Laryn, | FaDu |
| 2304- | CUR, | Curcumin decreases Warburg effect in cancer cells by down-regulating pyruvate kinase M2 via mTOR-HIF1α inhibition |
| - | in-vitro, | Lung, | H1299 | - | in-vitro, | BC, | MCF7 | - | in-vitro, | Cerv, | HeLa | - | in-vitro, | Pca, | PC3 | - | in-vitro, | Nor, | HEK293 |
| 2305- | CUR, | Mitochondrial targeting nano-curcumin for attenuation on PKM2 and FASN |
| - | in-vitro, | BC, | MCF7 |
| 2312- | CUR, | Dual Role of Reactive Oxygen Species and their Application in Cancer Therapy |
| - | Review, | Var, | NA |
| 2308- | CUR, | Counteracting Action of Curcumin on High Glucose-Induced Chemoresistance in Hepatic Carcinoma Cells |
| - | in-vitro, | Liver, | HepG2 |
| 2579- | CUR, | ART/DHA, | Curcumin-Artemisinin Combination Therapy for Malaria |
| - | in-vivo, | Nor, | 1- |
| 2466- | CUR, | Regulatory Effects of Curcumin on Platelets: An Update and Future Directions |
| - | Review, | Nor, | NA |
| 2688- | CUR, | Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 2654- | CUR, | Oxidative Stress Inducers in Cancer Therapy: Preclinical and Clinical Evidence |
| - | Review, | Var, | NA |
| 2819- | CUR, | Chemo, | Curcumin as a hepatoprotective agent against chemotherapy-induced liver injury |
| - | Review, | Var, | NA |
| 2820- | CUR, | Hepatoprotective Effect of Curcumin on Hepatocellular Carcinoma Through Autophagic and Apoptic Pathways |
| - | in-vitro, | HCC, | HepG2 |
| 2821- | CUR, | Antioxidant curcumin induces oxidative stress to kill tumor cells (Review) |
| - | Review, | Var, | NA |
| 2822- | CUR, | Identification of curcumin derivatives as human glyoxalase I inhibitors: A combination of biological evaluation, molecular docking, 3D-QSAR and molecular dynamics simulation studies |
| - | Analysis, | Nor, | NA |
| 2823- | CUR, | Binding of curcumin with glyoxalase I: Molecular docking, molecular dynamics simulations, and kinetics analysis |
| - | Study, | Nor, | NA |
| 2812- | CUR, | Curcumin Induces High Levels of Topoisomerase I− and II−DNA Complexes in K562 Leukemia Cells |
| - | in-vitro, | AML, | K562 |
| 2817- | CUR, | Neuroprotection by curcumin: A review on brain delivery strategies |
| - | Review, | Nor, | NA |
| 2811- | CUR, | Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study |
| - | Human, | Pca, | NA |
| 2810- | CUR, | Effect of curcuminoids on oxidative stress: A systematic review and meta-analysis of randomized controlled trials |
| - | Review, | Nor, | NA |
| 2809- | CUR, | Comparative absorption of curcumin formulations |
| - | in-vivo, | Nor, | NA |
| 2808- | CUR, | Iron chelation by curcumin suppresses both curcumin-induced autophagy and cell death together with iron overload neoplastic transformation |
| - | in-vitro, | Liver, | HUH7 |
| 2818- | CUR, | Novel Insight to Neuroprotective Potential of Curcumin: A Mechanistic Review of Possible Involvement of Mitochondrial Biogenesis and PI3/Akt/ GSK3 or PI3/Akt/CREB/BDNF Signaling Pathways |
| - | Review, | AD, | NA |
| 2813- | CUR, | Oxidative Metabolites of Curcumin Poison Human Type II Topoisomerases |
| - | Review, | Var, | NA |
| 2814- | CUR, | Curcumin in Cancer and Inflammation: An In-Depth Exploration of Molecular Interactions, Therapeutic Potentials, and the Role in Disease Management |
| - | Review, | Var, | NA |
| 2815- | CUR, | Biochemical and cellular mechanism of protein kinase CK2 inhibition by deceptive curcumin |
| - | in-vitro, | Nor, | NA |
| 2816- | CUR, | NEUROPROTECTIVE EFFECTS OF CURCUMIN |
| - | Review, | AD, | NA | - | Review, | Park, | NA |
| 2980- | CUR, | Inhibition of NF B and Pancreatic Cancer Cell and Tumor Growth by Curcumin Is Dependent on Specificity Protein Down-regulation |
| - | in-vivo, | PC, | NA |
| 2979- | CUR, | GB, | Curcumin overcome primary gefitinib resistance in non-small-cell lung cancer cells through inducing autophagy-related cell death |
| - | in-vitro, | Lung, | H157 | - | in-vitro, | Lung, | H1299 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid